RecruitingPHASE1, PHASE2NCT05116072

Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula

Studying Carcinoma of the ampulla of Vater

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Lille
Principal Investigator
François PATTOU, MD,PhD
University Hospital, Lille
Intervention
total pancreatectomy(procedure)
Enrollment
36 enrolled
Eligibility
18 years · All sexes
Timeline
20222030

Study locations (1)

Collaborators

Ministry of Health, France

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05116072 on ClinicalTrials.gov

Other trials for Carcinoma of the ampulla of Vater

Additional recruiting or active studies for the same condition.

See all trials for Carcinoma of the ampulla of Vater

← Back to all trials